Coronary chronic total occlusion
Conditions
Interventions
Exercise rehabilitation group:Exercise rehabilitation was carried out during hospitalization, during the early outpatient period of discharge, and during the latter part of discharge, and monitor inte
Shexiang baoxin pill group:Oral Shexiang baoxin pills, 2 pills, 3/day started after surgery.
Shexiang baoxin pill combined with exercise rehabilitation group:Combined Shexiang baoxin pill and exercise rehabilitation group interventions.
Control group:Routine postoperative management of PCI.
Sponsors
980th Hospital of the Joint Service Support Force of PLA
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Age > 18 years.not restricted to female or male; Patients with CTO by coronary angiography; Evidence of myocardial ischemia suitable for PCl treatment; Patients who understand the trial's purpose voluntarily participate and sign an informed consent form and are willing to undergo clinical follow-up as required by the study.
Exclusion criteria
Exclusion criteria: Cardiovascular and cerebrovascular accidents (acute myocardial infarction.cerebral hemorrhage. cerebral embolism. etc.) within half a year; Severe heart failure symptoms or left ventricular ejection fraction < 40%; Patients with severe renal insufficiency requiring dialysis; In patients with bleeding tendency history of active peptic ulcer.history of cerebral or subarachnoid hemorrhage.history of stroke within six months.contraindications to antiplatelet and anticoagulant therapy; Sick sinus node syndrome.second-degree type I or third-degree atrioventricular block; Unstable angina with resting angina episodes still present within 48h; Life expectancy < 12 months; Patients with significant limitations in exercise capacity; Poor compliance and inability to complete research as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coronary microcirculatory conditions;Incidence of angina pectoris; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Metabolic and nutritional conditions;Incidence of 1-year MACE event;Liver and kidney function;Incidence of in-hospital MACE events; | — |
Countries
China
Contacts
Public ContactYuying Zhao
980th Hospital of the Joint Service Support Force of PLA
Outcome results
None listed